| No images? Click here  29 August 2025 | Issue 319  Mental Health and Psychosocial Support mobile team’s visit to Aghveran, Armenia.   Tuesday, 02 September Release of new mental health data WHO is releasing new data that provides the most comprehensive snapshot to date of global efforts to improve mental health. The data will be compiled in two reports: World mental health today and Mental health atlas 2024. These reports are critical tools for policymakers, implementers and advocates in informing national strategies and global dialogue, particularly in the lead-up to the Fourth UN High-level Meeting of the UN General Assembly on the prevention and control of NCDs and the promotion of mental health and wellbeing in New York in September 2025. An embargoed virtual press conference will be held at 14.00 CEST on Monday, 1 September. A media advisory with additional details will be sent later. Embargoed copies of the press release and reports are available upon request to cdrysdale@who.int, with a copy to mediainquiries@who.int. Embargo lift: Tuesday, 02 September at 10.00 CEST / 08.00 GMT. ********** WHO training toolkit on substandard and falsified medical products 13.30 CEST, webinar The training toolkit on substandard and falsified medical products (SFMP), designed to equip healthcare professionals and regulators with the knowledge and tools needed to combat SFMP, will be presented at this webinar. Further information and registration: here.  Wednesday, 03 September Introducing Integrated Outbreak Analytics 13.00 CEST, EPI-WIN Webinar Integrated outbreak analytics (IOA) aims to support the successful detection, investigation and response to outbreaks in a contextual, holistic, sustainable, and accountable way. The IOA approach with country experiences and the recently published IOA toolkit will be introduced at this webinar. Further information and registration: here. ********** Launch of the French translation of WHO’s Guidance for Best Practices for Clinical Trials 14.00 CEST, webinar The webinar will highlight the importance of the WHO Guidance for Best Practices for Clinical Trials in strengthening clinical trial ecosystems, share country and regional experiences, and explore strategies for ethical and inclusive trial conduct, community engagement, and regional collaboration. The Guidance aims to improve the quality, coordination, and inclusiveness of clinical trials globally, with a focus on ensuring that research generates timely and reliable evidence for public health. The availability of the French version broadens access to this critical resource, supporting its implementation across Francophone countries and regions.  Thursday, 04 September Fifth meeting of the International Health Regulations (IHR) Emergency Committee on the mpox upsurge The fifth meeting of the Emergency Committee for the mpox upsurge, convened by the WHO Director-General under the International Health Regulations (IHR 2005), will be held on Thursday, 04 September 2025. Following their meeting, the Emergency Committee will advise the Director-General as to whether the mpox upsurge still constitutes a public health emergency of international concern (PHEIC). The decision of the Director-General following the advice of the Emergency Committee will be shared after the meeting. The Committee’s statement, once issued, will be shared with the media. ********** Release of the WHO updated Model Lists of Essential Medicines On Thursday, 04 September, WHO will release the updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), marking the 25th edition of the EML and the 10th edition of the EMLc. WHO Model Lists include medicines for the priority health needs of populations. First published in 1977 and updated every two years, they are adopted in over 150 countries, serving as a basis for public sector procurement, supply of medicines and health insurance, reimbursement schemes. Embargoed materials will be available to journalists on 03 September by request to mascheronisa@who.int, copy to mediainquiries@who.int. Embargo will lift at 17.00 CEST on Thursday, 04 September 2025. Also see: WHO Model Lists of Essential Medicines ********** Implementing vision and hearing screening in schools: a deep dive into the WHO handbook Sessions at 08.00 and 16.30 CEST, webinar The Vision and hearing screening for school-age children: implementation handbook provides practical guidance to help countries implement effective school-based screening programmes for vision and hearing. Its goal is to ensure early identification and timely intervention for children with sensory impairments, contributing to better health, learning, and life outcomes. Simultaneous interpretation in French, Spanish, and International Sign Language will be provided. The webinar offered in two slots to accommodate different time zones. Further information and registration: here. ********** Launch of Phase 2 of WHO’s Science and Policy Summaries on air pollution, energy access, climate change and health 14.00 CEST, webinar Air pollution continues to be one of the largest environmental risks to health, contributing to millions of deaths each year—especially among vulnerable groups such as children and those with noncommunicable diseases. Energy poverty and the worsening effects of climate change further compound these health threats. To support science-informed policy-making that protects health and promotes cleaner environments, the World Health Organization is launching Phase 2 of its Science and Policy Summaries (SPS) on Air Pollution, Energy Access, Climate Change, and Health. The SPS aims to equip decision-makers with robust, accessible evidence to support solutions for clean air, clean energy, and climate-resilient health systems. Further information and registration: here. ********** Webinar Series Launch: Strengthening Product Ecosystems for Maternal & Newborn Health 14.00 CEST, webinar Every Woman Every Newborn Everywhere, an initiative co-chaired by WHO, UNICEF and UNFPA, is launching a webinar series focused on breaking down silos and strengthening access to life-saving, quality maternal and newborn health products. This four-part series aims to develop a vision of “what good access looks like” and a framework of action that supports national progress. Further information and registration: here.  Stories of interest:
 WHO events here Sign up for our newsletters here Check out the WHO series, Science in 5 Catch a series that debunks misinformation around WHO and public health, Plot Twist Access WHO photos available for media use here  WHO media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list. |
Friday, August 29, 2025
WHO | Week Ahead for media - 29 August 2025
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment